Vemurafenib is a multi-targeted kinase inhibitor originally approved to treat melanoma patients with a BRAF mutation.
Specialty Pharmacy
Advertisement
New class of HIV medications called viral-entry inhibitors protect healthy cells from viral infection.
Advertisement
Top news of the day from across the health care landscape.
Veikira XR is a once-daily medication that treats hepatitis C genotype 1.
Compounds found in turmeric and milk thistle inhibit the spread of cancer cells.
A novel technique could resolve current problems with photo-thermal therapy for cancer treatment.
Advertisement
Kevin James, RPh, MBA, vice president of payer strategy at US Bioservices, discusses the impact of Accountable Care Organizations on specialty pharmacy.
Pharmacists can offer value to manufacturers, providers, patients, and payers.
Inferiority ruled for biosimilar of trastuzumab in the treatment of HER2-positive early breast cancer.
Microorganisms in the gut play a role in inflammation among patients with multiple sclerosis.
Advertisement
HIV infection rate among gay and bisexual men remains a problem.
Study finds global need for health care interventions that target diabetes.
New approach seeks to overcome chemotherapy resistance in cancer cells.
Colon cancer screenings are largely underutilized.
Precision medicine allows targeting of protein in acute myeloid leukemia.
Improved outcomes can position a specialty pharmacy to capitalize on projected specialty drug growth.
Growing HIV incidence in young individuals could cause epidemic to become worse.
Obese patients typically require higher doses of insulin therapy.
Top news of the day from across the health care landscape.
Vagus nerve stimulation may prove an effective RA treatment strategy.
Study evaluates the association between consuming butter and the development of diabetes and other chronic diseases.
CBX8 protein may lead to new treatments for breast cancer.
Protein that helps cancer cells survive during metastasis may lead to novel treatments.
Top articles of the week from The American Journal of Pharmacy Benefits.
Top articles of the week on Specialty Pharmacy Times.
ABT-414 receives designation for the treatment of diffuse intrinsic pontine glioma (DIPG).
Recent advances and updates in oncology and cancer drug development.
Synjardy expanded to include treatment naïve adults with type 2 diabetes.
Optimal channel selection should be made with the patient’s best interest at the center of the decision.
New initiative supports several research collaborations to find a cure for HIV/AIDS.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Pharmacists at the Forefront: Initiating, Monitoring, and Identifying Candidates for VMAT2 Therapy
2
mRNA COVID-19 Booster Outperforms Protein-Based Shot on Antibodies, But Both Cut Infections Over 12 Months
3
Building a Pharmacist-Led Furoscix Workflow From Scratch
4
Up to 5 Cups of Coffee Daily Safe—and Benficial—for Most Adults
5